Jul 27, 2023 / 12:00PM GMT
Operator
Ladies and gentlemen, welcome to Roche Half Year Results Webinar 2023. My name is Henrik, and I'm the technical operator for today's call. Kindly note that the webinar is being recorded. (Operator Instructions)
One last remark. If you would like to follow the presented slides on your end as well, please feel free to go to roche.com/investors to download the presentation.
At this time, it's my pleasure to introduce you to Thomas Schinecker, CEO, Roche Group. Mr. Schinecker, the stage is yours.
Thomas Schinecker - Roche Holding AG - CEO
Thank you very much, and hello, and welcome, everyone, to today's call. I'm looking forward to sharing our half year 2023 results with you. For the first half year of 2023, we saw the base business of both Pharma and Diagnostics divisions grew very strongly with a total of 8%. Group sales declined 2% at constant exchange rate, and this was due to the expected decline of sales from COVID-19 products. And this was in line with the guidance that we gave out in the beginning of the year of roughly CHF 5 billion for
Half Year 2023 Roche Holding AG Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers